Celebrating FIVE years of excellence, innovation, and teamwork at Javelin Biotech. A huge thank you to our team, clients, and partners who make it all possible. We’re grateful for the journey and excited for the future!
Javelin Biotech’s Post
More Relevant Posts
-
USD 116 million for safe, secure, sustainable transport of temperature-sensitive good: TOP 100 Swiss Scale-up SkyCell AG raises Series D to expand global operations. Applause for founders Nico Ros, Richard Ettl, and their ambitious team! https://lnkd.in/ebjtHcmj The Series D funding includes USD 59 million from Tybourne Capital Management and CC Industries, following a USD 57 million investment from Catalyst and M&G Investments. About: Every month, SkyCell containers protect more than USD 2.5 billion of pharmaceutical goods, including millions of doses of vaccines, cancer treatments, diabetes care, and diagnostic solutions for patients around the world. To boost its pharma customers' Scope 3 decarbonization, SkyCell is expanding its fleet to offer more solutions that cut CO2 emissions beyond the 50% already achieved by its containers. SkyCell ranked among the TOP 100 Scale-ups in 2021 and 2022. #TOP100SSU #SwissStartups
To view or add a comment, sign in
-
Looking forward to the BioTech company presentations and being inspired by the high level of innovation at this level! These conferences are always great for seeing what the future holds for patient populations who still have a high unmet need. Paola Valinotti's advice is just what these assets need to understand what is required to generate a successful outcome, further down the line. And at FINGERPOST, we're happy to bring the research, data, clinical and payer experts together to support Paola and others to deliver this. #marketaccess #pricing #forwardthinking #SwissBiotechDay
Patient & Market Access Leader, Advisor and Coach | Empowering organizations to accelerate PEOPLE access to healthCARE.
I'm delighted to announce my participation at the #SwissBiotechDay on April 22nd and 23rd in Basel. Alongside my partners at FINGERPOST, we provide tailored and efficient support to biotech companies to optimise exit, partnerships and product launches. I am looking forward to connect with many of you during the event and explore opportunities for collaboration! Swiss Biotech Association #Access2Health
To view or add a comment, sign in
-
🚀 Are you gearing up for a product launch? ImpactBio specializes in launch support and we're here to help you every step of the way. From strategic planning to execution, we've got you covered. Let's chat about how we can make your launch a memorable one! #LaunchSupport #ProductLaunch #Teamwork
Connect with the experts at ImpactBio to discuss how our team can support your next Product Launch. Reach out to Wendy Wolf via email today - Wendy.Wolf@Impact-Bio.com #Productlaunch #Launchexcellence #CSO #Projectmanagement #outsourcedsolutions
To view or add a comment, sign in
-
We were proud to be selected as one of the Fierce Biotech Fierce 15 2024 Honorees. We asked ourselves – what makes us fierce? Here is what our team said #7. We are caring: People at OMass care about each other as individuals, respecting and embracing our diverse experiences, backgrounds and perspectives. Really getting to know each other helps us feel connected and included. We are unselfish, appreciate each other and take time to help and support one another. Caring is a 360° thing, where team members care about each other, the company cares about us, and we care about the company. Read more about how OMassians are transforming lives together, our values and our team HERE: https://lnkd.in/ddaju6xf #innovation #biotech #drugdiscovery
To view or add a comment, sign in
-
How are we ending 2023 at ITICO Pharma? We share with you how we are guided by our #values to carry that positive energy into the #newyear. ☑ Celebrating achievements, big and small, and acknowledging the collective efforts that brought us here. ☑ Setting clear objectives for the upcoming year. ☑ Prioritizing projects based on purpose, impact and urgency. ☑ Collaborating together, promoting team unity and well-being. ☑ Working towards a common goal. #corporatevalues #celebratingachievements #teamappreciation
To view or add a comment, sign in
-
We’re excited to announce that PetVivo Holdings Inc. an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today its approval to dual list its shares on Upstream! 🎉 Trading becomes available on Upstream on March 5, 2024 at 10:00am ET under the ticker symbol “PETV”. The dual listing on Upstream is designed to provide PetVivo the opportunity to access a global, digital-first investor base outside the U.S. that can trade using credit, debit, PayPal, USD, or USDC; unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in PetVivo. “Building shareholder value is an ongoing goal of PetVivo. We believe a dual listing on Upstream is an excellent way to reach a worldwide market of potential investors who can learn about our Company and our innovative technologies designed and developed to enhance the lives of companion animals as well as their owners.” John Lai, Chief Executive Officer of PetVivo. 🔗 Learn more about the listing here: https://lnkd.in/epJR7BtW MERJ Exchange #duallisting #securities #PETV #UpstreamDualListings
To view or add a comment, sign in
-
Hear from Dan Deardorf CEO of Glycologix, as he shares his insights on how pivotal InnoVenture Labs has been in helping his company #GoFurtherFaster!
To view or add a comment, sign in
-
Enthusiastic about all things alive. CEO at VALANX Biotech - Site-specific protein conjugation without the hassle
One company optimizing protein conjugates, one company screening for optimal efficacy and therapeutic window of protein conjugates. Well played, #RESIBoston2024 #ADCs #startup #proteinconjugation
FluoSphera and VALANX Biotech here at RESI participating in the Innovator's Pitch Challenge at RESI Boston today - Best of luck today. #RESIBoston2024
To view or add a comment, sign in
-
🌟 Big news for Citeline! 🌟 We’re thrilled about our new partnership with Greenphire, a game-changer for how we build the next generation of our products! 🚀 With Greenphire’s proprietary financial data, we’re boosting our expert insights and unlocking even deeper clinical trial, site, and investigator performance data (and much more!) 📊 Combine that with Citeline’s data mastery, tech capabilities, and predictive algorithms – and we’re taking our best-in-class datasets to incredible new heights! 🙌✨ This means even better insights and recommendations for our clients. Stay tuned for more updates on how we’re integrating Greenphire’s data into our products. Exciting things are on the way! 👀🔍 #Partnership #Innovation #DataDriven #ClinicalTrials #PharmaInsights #Citeline
We are proud to join forces with Greenphire, this partnership is a huge step in how we will create next generation products at Citeline. Read how our complementary datasets will support sponsors and CROs in clinical trial planning! https://ow.ly/2TwM50Tj6OZ.
To view or add a comment, sign in
-
🎉 We recently released some brand-new videos showcasing Inpart's journey, values, and the fantastic team behind our success. Watch our introductory video to learn how we enable partnerships helping bring science to life ✨ #biopharma #biopharmapartnering #techtransfer #openinnovation #knowledgeexchange
To view or add a comment, sign in
1,225 followers